India: True North to buy 2.4% stake in Biocon Biologics at $3b valuation

India: True North to buy 2.4% stake in Biocon Biologics at $3b valuation

Biocon Chairperson Kiran Mazumdar-Shaw. Photo: Reuters

Leroy Leo

07 January, 2020

Biocon BiologicsTrue North

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.